These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 7511069)

  • 1. Segmental transarterial chemoembolization with Lipiodol mixed with anticancer drugs for nonresectable hepatocellular carcinoma: follow-up CT and therapeutic results.
    Nishimine K; Uchida H; Matsuo N; Sakaguchi H; Hirohashi S; Nishimura Y; Guo Q; Ohishi H; Nagano N; Yoshioka T
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S60-8. PubMed ID: 7511069
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Usefulness of segmental Lp-TAE using lipiodol mixed with anticancer agent for inoperable hepatocellular carcinoma].
    Matsuo N; Nishimine K; Uchida H; Nagano N; Nishimura Y; Oiyong G; Sakaguchi H; Yoshioka T; Ohue S; Ohishi H
    Nihon Shokakibyo Gakkai Zasshi; 1992 Jul; 89(7):1415-24. PubMed ID: 1325006
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Behavior of anti-cancer drug of transcatheter hepatic segmental arterial chemoembolization using lipiodol mixed with an anti-cancer drug followed by gelatin sponge assessed by Tc-99m pertechnetate].
    Sakaguchi H; Yoshimura H; Nishimura Y; Iwata K; Ohishi H; Uchida H
    Gan To Kagaku Ryoho; 1990 Aug; 17(8 Pt 2):1725-30. PubMed ID: 2167644
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Optimal lipiodol volume in transcatheter arterial chemoembolotherapy for hepatocellular carcinoma: study based on lipiodol accumulation patterns and histopathologic findings.
    Matsuo N; Uchida H; Sakaguchi H; Nishimine K; Nishimura Y; Hirohashi S; Ohishi H
    Semin Oncol; 1997 Apr; 24(2 Suppl 6):S6-61-S6-70. PubMed ID: 9151919
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Transcatheter hepatic subsegmental arterial chemoembolization therapy using iodized oil for small hepatocellular carcinomas. Correlation between lipiodol accumulation pattern and local recurrence.
    Murakami R; Yoshimatsu S; Yamashita Y; Sagara K; Arakawa A; Takahashi M
    Acta Radiol; 1994 Nov; 35(6):576-80. PubMed ID: 7946681
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Combined transjugular intrahepatic portosystemic shunt and segmental Lipiodol hepatic artery embolization for the treatment of esophagogastric varices and hepatocellular carcinoma in patients with cirrhosis: preliminary report.
    Sakaguchi H; Uchida H; Maeda M; Matsuo N; Kichikawa K; Ohishi H; Nishida H; Ueno K; Nishimine K; Rösch J
    Cardiovasc Intervent Radiol; 1995; 18(1):9-15. PubMed ID: 7540504
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Treatment of hepatocellular carcinoma by segmental SMANCS Lipiodol-TAE].
    Hayashi T; Uchida H; Matsuo N; Sakaguchi H; Anai H; Tanaka T; Yamamoto T; Ooue S; Yoshioka T; Makutani S; Oishi H
    Gan To Kagaku Ryoho; 1998 Feb; 25 Suppl 1():116-24. PubMed ID: 9512699
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chemoembolization therapy in small hepatocellular carcinoma].
    Uchida H; Matsuo N; Sakaguchi H; Nishimine K; Anai H; Ohishi H
    Gan To Kagaku Ryoho; 1996 Jun; 23(7):840-8. PubMed ID: 8678531
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Subsegmental transcatheter arterial embolization for hepatocellular carcinoma in the caudate lobe.
    Terayama N; Miyayama S; Tatsu H; Yamamoto T; Toya D; Tanaka N; Mitsui T; Miura S; Fujisawa M; Kifune K; Matsui O; Takashima T
    J Vasc Interv Radiol; 1998; 9(3):501-8. PubMed ID: 9618113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Segmental transcatheter hepatic artery chemoembolization with iodized oil for hepatocellular carcinoma: antitumor effect and influence on normal tissue.
    Matsuo N; Uchida H; Nishimine K; Soda S; Oshima M; Nakano H; Nagano N; Nishimura Y; Yoshioka T; Guo Q
    J Vasc Interv Radiol; 1993; 4(4):543-9. PubMed ID: 8394758
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term results of lipiodol-transcatheter arterial embolization with cisplatin or doxorubicin for unresectable hepatocellular carcinoma.
    Ono Y; Yoshimasu T; Ashikaga R; Inoue M; Shindou H; Fuji K; Araki Y; Nishimura Y
    Am J Clin Oncol; 2000 Dec; 23(6):564-8. PubMed ID: 11202797
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interventional radiology for advanced hepatocellular carcinoma: comparison of hepatic artery infusion chemotherapy and transcatheter arterial lipiodol chemoembolization.
    Sumie S; Yamashita F; Ando E; Tanaka M; Yano Y; Fukumori K; Sata M
    AJR Am J Roentgenol; 2003 Nov; 181(5):1327-34. PubMed ID: 14573429
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Volumetric and morphological CT parameters for assessing prognosis and treatment control in hepatocellular carcinoma undergoing arterial chemoembolization].
    Vogl TJ; Trapp M; Pegios W; Mack M; Bechstein WO; Keck W; Scholz A; Schröder H; Neuhaus P; Felix R
    Rofo; 1997 Sep; 167(3):219-26. PubMed ID: 9376548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combination therapy consisting of arterial infusion chemotherapy (EPF, EAP) and transcatheter arterial embolization (TAE).
    Yodono H; Takekawa SD; Tarusawa K; Ikami I; Kanehira J; Saito Y; Takahashi S; Sasaki T; Nishi N; Kimura T
    Cancer Chemother Pharmacol; 1994; 33 Suppl():S79-83. PubMed ID: 8137489
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of Lipiodol in transcatheter arterial embolization of hepatocellular carcinoma.
    Nakao N; Uchida H; Kamino K; Nishimura Y; Ohishi H; Takayasu Y; Nakamura H; Kuroda C; Fujita M; Yoshioka H
    Cancer Chemother Pharmacol; 1992; 31 Suppl():S72-6. PubMed ID: 1333913
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Long-term outcome of transcatheter subsegmental and segmental arterial chemoemobolization using lipiodol for hepatocellular carcinoma.
    Takaki S; Sakaguchi H; Anai H; Tanaka T; Yamamoto K; Morimoto K; Nishiofuku H; Inoue M; Sueyoshi S; Nagata T; Hidaka T; Uchida H; Kichikawa K
    Cardiovasc Intervent Radiol; 2012 Jun; 35(3):544-54. PubMed ID: 21739345
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Superselective hepatic segmental-subsegmental arterial chemoembolization using lipiodol mixed with an anticancer drug (segmental Lp-TAE)].
    Uchida H; Matsuo N; Nishimine K; Ohishi H
    Nihon Rinsho; 1991 Aug; 49(8):1898-904. PubMed ID: 1664896
    [No Abstract]   [Full Text] [Related]  

  • 18. [Treatment of hepatocellular carcinoma by transarterial approach].
    Luo PF
    Zhonghua Yi Xue Za Zhi; 1993 Mar; 73(3):158-60, 191. PubMed ID: 8391913
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Lipiodol retention and massive necrosis after lipiodol-chemoembolization of hepatocellular carcinoma: correlation between computed tomography and histopathology.
    Imaeda T; Yamawaki Y; Seki M; Goto H; Iinuma G; Kanematsu M; Mochizuki R; Doi H; Saji S; Shimokawa K
    Cardiovasc Intervent Radiol; 1993; 16(4):209-13. PubMed ID: 8402781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trans-catheter hepatic arterial injection of lipiodol soluble anti-cancer agent SMANCS and ADR suspension in lipiodol combined with arterial embolization and local hyperthermia for treatment of hepatocellular carcinoma.
    Yumoto Y; Jinno K; Tokuyama K; Wada T; Kobashi H; Okamoto T; Toki H; Inatsuki S; Hara K; Moriwaki S
    Int J Hyperthermia; 1991; 7(1):7-17. PubMed ID: 1711090
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.